Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Jeong Chan Ra, Gyeonggi-Do, KR

Jeong Chan Ra, Gyeonggi-Do, KR

Patent application numberDescriptionPublished
20080286243Method For Isolation of a Hair Follicle Stem Cell and a Composition For Hair Reproduction - The present invention relates to a method for isolating hair follicle stem cells and a composition for inducing hair growth. More specifically, relates to a method for isolating hair follicle stem cells showing a positive immunological response to CD34, by chemically degrading hair follicle-containing scalp tissue and then culturing the degraded tissue in a serum-containing medium and a serum-free medium, as well as a composition for inducing hair growth, which contains, as an active ingredient, CD34-positive hair follicle stem cells isolated by the method. The hair follicle-derived stem cells, which are obtained according to the disclosed method, are classified as autologous adult stem cells, have self-renewal capability, the ability to differentiate into adult hair follicle cells and the ability to induce hair growth, and can be used as a novel cell therapeutic agent against hair loss. In addition, the present invention relates to a method for culturing hair follicle cells, which has high yield compared to that of the prior art, as well as a method for identifying hair follicle stem cells.11-20-2008
20090142418ANTIVIRAL COMPOSITION COMPRISING ALNUS JAPONICA EXTRACTS - Antiviral compositions including 06-04-2009
20090175963ANTIVIRAL COMPOSITION COMPRISING LYCORIS SQUAMIGERA EXTRACTS - Antiviral compositions including 07-09-2009
20100189827ANTIVIRAL COMPOSITION COMPRISING ALNUS JAPONICA EXTRACTS - Antiviral compositions including 07-29-2010
20100196329COMPOSITION FOR TREATING ISCHEMIC LIMB DISEASE COMPRISING STEM CELLS DERIVED FROM ADIPOSE TISSUE - Disclosed herein is a cell therapeutic composition for treating ischemic limb diseases, more specifically, disclosed is a cell therapeutic composition for treating ischemic diseases, which contains adipose tissue-derived mesenchymal stem cells and sucrose or mannose as an excipient. The composition induces angiogenesis around closed blood vessels in the ischemic limb lesions, and thus is useful to treat ischemic diseases.08-05-2010
20100266553METHOD FOR ISOLATING AND CULTURING ADULT STEM CELLS DERIVED FROM HUMAN AMNIOTIC EPITHELIUM - The present invention relates to a method for isolating and culturing adult stem cells derived from human amniotic membrane in high yield, and more particularly to a method for obtaining a large amount of adult stem cells, the method comprising obtaining amniotic epithelial cells from human amniotic tissue in high yield by treatment with dithiothreitol (DTT) and a low concentration of trypsin and culturing the amniotic epithelial cells in a medium containing a Rho-associated kinase inhibitor. The human amniotic epithelial cell-derived stem cells are easily extracted compared to existing therapeutic stem cells such as umbilical cord blood stem cells and bone marrow stem cells, the yield and proliferation thereof are significantly increased by DTT treatment, the addition of the ROCK inhibitor or the replacement of medium. Thus, the method can be used to efficiently prepare adult stem cells.10-21-2010
20100272836COMPOSITION FOR INCREASING MILK PRODUCTION CONTAINING ARTEMISIA CAPILLARIS - The present invention relates to a composition for increasing the milk production of livestock, containing 10-28-2010
20100285160ANTI-INFLUENZA VIRAL COMPOSITION CONTAINING BARK OR STEM EXTRACT OF ALNUS JAPONICA - The present invention relates to an antiviral composition comprising an 11-11-2010
20110059052CELLULAR THERAPEUTIC AGENT FOR INCONTINENCE OR URINE COMPRISING STEM CELLS ORIGINATED FROM DECIDUA OR ADIPOSE - The present invention relates to a cellular therapeutic agent for treating urinary incontinence, and more particularly to a cellular therapeutic agent for treating urinary incontinence, which contains stem cells derived from the decidua of the placenta or menstrual fluid or stem cells derived from adipose. The decidua-derived stem cells or adipose-derived stem cells show the effects of increasing leak point pressure and urethral sphincter contractility, and thus are useful as an agent for treating urinary incontinence.03-10-2011
20110098239NOVEL DIARYL HEPATONOID-BASED COMPOUNDS AND USE THEREOF - The present invention relates to a diaryl hepatonoid-based compound of formula (1) having viral inhibitory activity; its pharmaceutically acceptable salt; or a hydrate, a solvate or a prodrug of any of the foregoing, and a pharmaceutical composition comprising the same, and the use thereof therapeutic agents. The diaryl hepatonoid-based compounds according to present invention have an excellent effect of inhibiting viral activity, and thus will be useful as therapeutic agents against virus-related diseases.04-28-2011
20110098261TRITERPENOID-BASED COMPOUNDS USEFUL AS VIRUS INHIBITORS - The present invention relates to the use of triterpenoid-based compounds of formula (1) for inhibiting viral activity. The triterpenoid-based compounds have an excellent effect of inhibiting viral activity, and thus will be useful as therapeutic agents against virus-related diseases.04-28-2011
20110105738DIARYL HEPATONOID-BASED COMPOUNDS USEFUL AS VIRUS INHIBITORS - The present invention relates to the use of diaryl hepatonoid-based compounds of formula (1) for inhibiting viral activity. The diaryl hepatonoid-based compounds have an excellent effect of inhibiting viral activity, and thus will be useful as therapeutic agents against virus-related diseases.05-05-2011
20110124740NOVEL DIARYL HEPATONOID-BASED COMPOUNDS AND USE THEREOF - The present invention relates to a diaryl hepatonoid-based compound of formula (1) having viral inhibitory activity; its pharmaceutically acceptable salt; or a hydrate, a solvate or a prodrug of any of the foregoing, and a pharmaceutical composition containing the same, and the use thereof therapeutic agents. The diaryl hepatonoid-based compound has an excellent effect of inhibiting viral activity, and thus will be useful as therapeutic agents against virus-related diseases.05-26-2011
20110144039ANTIOXIDATIVE AND HEPATOPROTECTIVE COMPOSITIONS CONTAINING DIARYHEPTANOIDS FROM ALNUS JAPONICA - The present invention relates to antioxidative and hepatoprotective compositions, and more particularly to antioxidative and hepatoprotective compositions comprising diarylheptanoid compounds from 06-16-2011

Patent applications by Jeong Chan Ra, Gyeonggi-Do, KR